Research Topics
Species | Jamal ZidanSummaryCountry: Israel Publications
| Collaborators
|
Detail Information
Publications
Prevention of chemotherapy-induced neutropenia by special honey intakeJamal Zidan
Oncology Unit, Sieff Hospital, Safed, Israel
Med Oncol 23:549-52. 2006..The use of LMH in patients who are at high risk of developing neutropenia as a result of chemotherapy decreases the risk of pancytopenia and the need for CSFs. LMH is inexpensive, has no side effects, and is easy to administer...- Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancerJamal Zidan
Oncology Unit, Sieff Government Hospital, Safed, Israel
Med Oncol 21:117-21. 2004..Changes in serum concentration of biochemical markers may reflect decreased bone turnover or bone remodeling and add to the understanding of tamoxifen's effect on bone mineral density... - Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancerJamal Zidan
Oncology Unit, Sieff Government Hospital, PO Box 1008, Safed 13100, Israel
Int J Radiat Oncol Biol Phys 59:1330-6. 2004..The current study was conducted to determine the optimal dose of I(131) for remnant postoperative ablation. A review of the literature is included... - Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphomaJamal Zidan
Oncology Unit, Sieff Government Hospital, POB 1008, Safed, Israel
Oncologist 9:417-21. 2004..The aim of the current study is to evaluate CA125 levels in patients with NHL and to investigate the correlations between high CA125 level and other presenting features... - Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic diseaseJ Zidan
Oncology Unit, Sieff Government Hospital, Safed, Israel
Br J Cancer 93:552-6. 2005..Our data suggest that a possible discordance of HER-2 overexpression between primary and metastases should be considered when making treatment decisions in patients with primary HER-2-negative tumours... - Oral premedication for the prevention of hypersensitivity reactions to paclitaxelJamal Zidan
Oncology Unit, Ziv Medical Center, POB 1008, Zefat 13100, Israel
Med Oncol 25:274-8. 2008..This strategy is feasible, gives excellent results in reducing hypersensitivity reactions and shortens the time of treatment for patients and treating staff... - Effect of letrozole on plasma lipids, triglycerides, and estradiol in postmenopausal women with metastatic breast cancerJamal Zidan
Ziv Medical Center, Safed, Israel
Oncologist 15:1159-63. 2010..The aim of this prospective study was to evaluate the effect of letrozole on plasma lipids, triglyceride lipase (TGL), and estradiol levels in women with metastatic breast cancer (MBC). Materials and.. - Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survivalJamal Zidan
Oncology Unit, Sieff Government Hospital, Safed, Israel
Cancer 97:1181-5. 2003..A retrospective study was performed to identify the influence of FVPTC compared with PTC on therapeutic variables, prognostic variables, and survival... - Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg
Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Haifa, Israel
Gynecol Oncol 108:298-305. 2008..Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease... - Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapyJamal Zidan
Oncology Unit, Sieff Government Hospital, Safed, Israel
Isr Med Assoc J 4:597-9. 2002..Chemical agents used for third and fourth-line therapy usually yield poor results with severe toxic side effects... - Interstitial brachytherapy in soft tissue sarcomas: the Rambam experienceEdward Rosenblatt
Brachytherapy Unit, Department of Oncology, Rambam Medical Center, Technion Faculty of Medicine, Haifa, Israel
Isr Med Assoc J 5:547-51. 2003..There are radiobiologic and technical advantages to the use of interstitial brachytherapy alone or as an adjunct to external beam radiotherapy in the postoperative treatment of soft tissue sarcomas... - Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000Eliahu Gez
Department of Oncology, Rambam Medical Center, Haifa, Israel
Cancer 95:1644-9. 2002..The current study evaluated the efficacy and toxicity of interleukin-2 (IL-2), interferon-alpha (IFN-alpha), 5-fluorouracil (5-FU), and vinblastine (VBL) in the treatment of metastatic renal cell carcinoma (MRCC)... - First-line treatment with capecitabine combined with irinotecan in patients with advanced colorectal carcinoma: a phase II studyNimer Assy
Liver Unit, Technion Israel Institute of Technology, Haifa, Israel
J Clin Gastroenterol 46:e27-30. 2012..To evaluate the efficacy and toxicity of capecitabine with irinotecan as first-line treatment in metastatic colorectal cancer... - Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern IsraelYelena Glushko
Oncology Institute, Ziv Medical Center, Zefat, 13100, Israel
Fam Cancer 9:327-30. 2010..Arab patients are younger at the time of diagnosis. Screening for CRC should be started at earlier age in the Arab population than the population at large... - Curcuma as a functional food in the control of cancer and inflammationMoshe Schaffer
Institute of Oncology, Ziv Medical Center, Faculty of Medicine, Zefat, Israel
Curr Opin Clin Nutr Metab Care 14:588-97. 2011..Extensive research over the past half century and especially in recent years has revealed important functions of curcumin and a timely review of clinical state-of-the-art using curcumin... - Characteristics of common solid liver lesions and recommendations for diagnostic workupNimer Assy
Liver Unit, Ziv Medical Center, Zefat 13100, Israel
World J Gastroenterol 15:3217-27. 2009..If the patient is known to have a primary malignancy and the lesion was found at tumor staging or follow up, histology is required only when the nature of the liver lesion is doubtful... - Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatinOsamah Hussein
Department of Internal Medicine A, Ziv Medical Centre, Safed, Israel
Br J Clin Pharmacol 65:637-45. 2008..WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Statins demonstrate a pleiotropic effect which contributes beyond the hypocholesterolaemic effect to prevent atherosclerosis... - A novel MSH2 germline mutation in a Druze HNPCC familyJamal Zidan
Oncology Unit, Rivkah Ziv Medical Center, Zefat, Israel
Fam Cancer 7:135-9. 2008..This is the first mutation ever reported in a colon cancer susceptibility gene in a Druze family and it appears not to be a founder mutation in Druze individuals with HNPCC... - Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findingsSarah Kohn
Electron Microscopy Unit, The Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Ultrastruct Pathol 26:371-82. 2002.... - The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriersInbar Gal
Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Genetics, Chaim Sheba Medical Center, Tel Hashomer, Israel
Fam Cancer 3:11-4. 2004....